Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sun's Yiqi Jianpi Tongbian Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Beijing Hepingli Hospital for the treatment of pediatric functional constipation. The formula is specifically designed to address the 'spleen deficiency and intestinal dryness' pattern, a common TCM syndrome in children characterized by chronic constipation. Its therapeutic goals are to supplement Qi (Yiqi), strengthen the spleen (Jianpi), and facilitate bowel movements (Tongbian) by moistening the intestines. The formula is administered in a granule dosage form and has been evaluated in clinical trials to determine its dose-effect relationship, efficacy, and safety compared to standard osmotic laxatives like lactulose in pediatric patients aged 4 to 14 years.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sun's Yiqi Jianpi Tongbian Formula.